Fund profile

MB Venture Partners

United States

Leading

About

in 2001, MBVP primarily focuses on medical device startups, particularly those addressing musculoskeletal diseases. Notable investments include startups acquired by industry giants like Johnson & Johnson, Medtronic, Smith + Nephew, Zimmer Biomet, and Wright Medical (now part of Stryker). MBVP's strategy emphasizes providing not just capital but also strategic direction, leveraging their deep industry connections and expertise. They typically invest at all stages of development, ensuring that startups have the support they need from inception through to exit. The firm is known for its active role in the Musculoskeletal New Ventures Conference, a testament to its leadership in the sector. The team is led by co-founder Gary Stevenson, whose background includes significant roles in healthcare investment banking, equity research, and general management at Abbott Laboratories. Gary's comprehensive experience and his educational background, including an MBA from Northwestern University's Kellogg School of Management, underscore the firm's robust leadership. MBVP prefers to be approached by startups with a clear, compelling value proposition in the life sciences sector. They are known for writing substantial checks and often lead investment rounds. Their involvement in over 50 startups highlights their active investment approach and commitment to advancing medical innovations​.

Details

Round

SeedSeries ASeries BSeries C+

Geo focus

Highlights

$304.7k

Historical average check

$11M

Historical max check

May 2020

Last investment date

90

Investments

Healthtech & Wellness

Biotech

Natural Resources

Hardware. Robotics & IoT

Pharma

Software & Apps

Funds that also invest in Biotech